Tweetovi

Blokirali ste korisnika/cu @CircAHA

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @CircAHA

  1. Prikvačeni tweet
    23. pro 2019.

    Call for Papers! Circulation again invites submissions representing the best of cardiovascular surgery science for the 2020 Cardiovascular Surgery-Themed Issue. Submit by March 1, 2020. Learn More: Read the previous issue here:

    Poništi
  2. proslijedio/la je Tweet
    prije 4 sata

    Stent Only vs Adjunctive Balloon for No difference in target vessel failure but ⬇️ST and MI with direct stenting(No 🎈) by et al

    Poništi
  3. prije 19 sati

    : Substance and Substrate: LVEF and Sex Subgroup Analyses of PARAGON-HF and PARADIGM-HF Trials

    Poništi
  4. prije 20 sati

    : In combined PARADIGM/PARAGON-HF analysis, benefit of sacubitril/valsartan varies by LVEF, extends to . Read more:

    Poništi
  5. prije 21 sat

    : In PARAGON-HF, sacubitril/valsartan reduced risk of HF hospitalization in women more than in men. Read more:

    Poništi
  6. proslijedio/la je Tweet
    prije 23 sata
    Poništi
  7. 4. velj

    : Abolish the Tilt Table Test!

    Poništi
  8. 3. velj

    episode featuring corresponding author, & Senior Associate Editor, discussing Sacubitril/Valsartan Across Ejection Fraction Spectrum Featured Article:

    Poništi
  9. 3. velj

    AHA Presidential Advisory: Advancing Healthcare Reform: The AHA’s 2020 Statement of Principles for Adequate, Accessible & Affordable Health Care

    Poništi
  10. 1. velj

    episode featuring corresponding author, and associate editors, Dr. Dharam Kumbhani & discussing THV Design, PVR, & Mortality Featured Article:

    Poništi
  11. 31. sij

    Call for Papers! Submit your best cardiovascular surgery science for Circulation's 2020 Cardiovascular Surgery-Themed Issue. Submission deadline: March 1, 2020. Learn More: Read the previous issue here:

    Poništi
  12. proslijedio/la je Tweet
    31. sij

    TWEET CHAT! This Sunday (2/2) from 11AM–12PM EST...Join the Twitter Journal Club and David Fischman, MD for a discussion on Ischemia and No Obstructive Coronary Artery Disease . Use to participate. More info:

    Ischemia and No Obstructive Coronary Artery Disease: Prevalence and Correlates of Coronary Vasomotion Disorders
    Poništi
  13. 31. sij

    A rare subset of due to mutations in MYL4 appears to be dependent on pathways previously implicated in cardiac development

    Poništi
  14. 30. sij

    Transient treatment of human iPSC-derived cardiomyocytes with Torin1, a mTOR inhibitor, shifts cells to a quiescent state and enhances cardiomyocyte maturity

    Poništi
  15. 30. sij
    Poništi
  16. 29. sij

    Heart Disease & Stroke Statistics—2020 Update

    Poništi
  17. 29. sij

    : Recommendations for Cardiovascular Health and Disease Surveillance for 2030 and Beyond: A Policy Statement From the American Heart Association

    Poništi
  18. 29. sij

    AHA Policy Statement: Recommendations for CV Health and Disease Surveillance for 2030 and Beyond

    Poništi
  19. 29. sij

    AHA Presidential Advisory: The AHA 2030 Impact Goal

    Poništi
  20. 28. sij

    : Transcatheter heart valve design and mortality: truth or dare?

    Poništi
  21. 28. sij

    Balloon-expandable was associated with lower mortality, rehospitalization and pacemaker implantation compared with self-expanding

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·